1
|
Jiang Y, He S, Xiang N, Duan L, Lin Y, Huang W, Wu Z, Qi X. A copper missile-triggered power coalescence and death vortex within tumor cell mitochondria for synergistic cuproptosis/phototherapy/chemotherapy. NANOSCALE 2024; 16:15967-15983. [PMID: 39101331 DOI: 10.1039/d4nr02382j] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/06/2024]
Abstract
The importance of copper homeostasis in mitochondria and copper-triggered modality of mitochondrial cell death have been confirmed. However, the existing copper-based nanoplatforms are focused on synergistic therapies while the intracellular therapeutic targets are relatively scattered. Effective integration of all targets within mitochondria to generate power coalescence remains a challenge. Herein, we developed a novel copper-based delivery system to trigger power coalescence and death vortex within tumor cell mitochondria. Specifically, a mitochondrial targeting "copper missile" loaded with curcumin (termed as Cur@CuS-TPP-HA, CCTH) was designed for cuproptosis/phototherapy/chemotherapy synergistic anti-tumor therapy. Once the CCTH NPs are shuttled to the mitochondria, near-infrared (NIR) irradiation initiates the release of copper ions and curcumin for in situ drug accumulation in cancer cell mitochondria. An excess of copper ions and curcumin can activate cuproptosis and mitochondrial apoptosis pathways, respectively. When combined, they can cause an increase in reactive oxygen species (ROS), damage to mitochondrial DNA (mt-DNA), and a decrease in energy supply, thereby leading to a "vicious circle" of mitochondrial damage that further enhances the tumor-killing efficacy. As a consequence, this "copper missile" exhibits advanced anti-tumor effects as verified through in vitro assessments and in vivo evaluations using the 4T1 breast tumor model, providing a promising approach for cuproptosis-based synergistic anti-tumor therapy.
Collapse
Affiliation(s)
- Yicheng Jiang
- Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
- Center of Advanced Pharmaceuticals and Biomaterials, Ningbo Institute of Marine Medicine, Peking University, Ningbo 315832, China
| | - Shuhan He
- Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
| | - Niu Xiang
- Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
| | - Linghui Duan
- Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
| | - Yuxiang Lin
- Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
| | - Wenyu Huang
- Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
| | - Zhenghong Wu
- Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
| | - Xiaole Qi
- Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Nanjing 210009, PR China.
- Industrial Technology Innovation Platform, Zhejiang Center for Safety Study of Drug Substances, Hangzhou 310018, China.
| |
Collapse
|
2
|
Khaket TP, Singh MP, Khan I, Kang SC. In vitro and in vivo studies on potentiation of curcumin-induced lysosomal-dependent apoptosis upon silencing of cathepsin C in colorectal cancer cells. Pharmacol Res 2020; 161:105156. [DOI: 10.1016/j.phrs.2020.105156] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/31/2020] [Revised: 08/04/2020] [Accepted: 08/12/2020] [Indexed: 12/29/2022]
|
3
|
Wu LY, Chen CW, Chen LK, Chou HY, Chang CL, Juan CC. Curcumin Attenuates Adipogenesis by Inducing Preadipocyte Apoptosis and Inhibiting Adipocyte Differentiation. Nutrients 2019; 11:nu11102307. [PMID: 31569380 PMCID: PMC6836120 DOI: 10.3390/nu11102307] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Revised: 08/09/2019] [Accepted: 09/10/2019] [Indexed: 12/23/2022] Open
Abstract
Patients with metabolic syndrome are at an increased risk of developing type 2 diabetes and cardiovascular diseases. The principal risk factor for development of metabolic syndrome is obesity, defined as a state of pathological hyperplasia or/and hypertrophy of adipose tissue. The number of mature adipocytes is determined by adipocyte differentiation from preadipocytes. The purpose of the present study is to investigate the effects of curcumin on adipogenesis and the underlying mechanism. To examine cell toxicity of curcumin, 3T3-L1 preadipocytes were treated with 0–50 µM curcumin for 24, 48, or 72 h, then cell viability was measured using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The effect of curcumin on the cell cycle was determined by flow cytometry. Curcumin-induced cell apoptosis was determined by the TUNEL assay and curcumin-induced caspase activation was measured by immunoblotting. The effect of curcumin on adipocyte differentiation was determined by measuring mitotic clonal expansion (MCE), expression of adipogenic transcription factors, and lipid accumulation. Results showed the viability of preadipocytes was significantly decreased by treatment with 30 µM curcumin, a concentration that caused apoptosis in preadipocytes, as assessed by the TUNEL assay, and caused activation of caspases 8, 9, and 3. A non-cytotoxic dose of curcumin (15 µM) inhibited MCE, downregulated the expression of PPARγ and C/EBPα, prevented differentiation medium-induced β-catenin downregulation, and decreased the lipid accumulation in 3T3-L1 adipocytes. In conclusion, our data show that curcumin can induce preadipocyte apoptosis and inhibit adipocyte differentiation, leading to suppression of adipogenesis.
Collapse
Affiliation(s)
- Liang-Yi Wu
- Department of Bioscience Technology, College of Science, Chung-Yuan Christian University, Chung Li 32023, Taiwan.
| | - Chien-Wei Chen
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
- College of Human Development and Health, National Taipei University of Nursing and Health Sciences, Taipei 11219, Taiwan.
| | - Luen-Kui Chen
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
| | - Hsiang-Yun Chou
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
| | - Chih-Ling Chang
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
| | - Chi-Chang Juan
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan.
- Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
| |
Collapse
|
4
|
Minafra L, Porcino N, Bravatà V, Gaglio D, Bonanomi M, Amore E, Cammarata FP, Russo G, Militello C, Savoca G, Baglio M, Abbate B, Iacoviello G, Evangelista G, Gilardi MC, Bondì ML, Forte GI. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells. Sci Rep 2019; 9:11134. [PMID: 31366901 PMCID: PMC6668411 DOI: 10.1038/s41598-019-47553-2] [Citation(s) in RCA: 63] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2019] [Accepted: 07/10/2019] [Indexed: 12/12/2022] Open
Abstract
In breast cancer (BC) care, radiotherapy is considered an efficient treatment, prescribed both for controlling localized tumors or as a therapeutic option in case of inoperable, incompletely resected or recurrent tumors. However, approximately 90% of BC-related deaths are due to the metastatic tumor progression. Then, it is strongly desirable to improve tumor radiosensitivity using molecules with synergistic action. The main aim of this study is to develop curcumin-loaded solid nanoparticles (Cur-SLN) in order to increase curcumin bioavailability and to evaluate their radiosensitizing ability in comparison to free curcumin (free-Cur), by using an in vitro approach on BC cell lines. In addition, transcriptomic and metabolomic profiles, induced by Cur-SLN treatments, highlighted networks involved in this radiosensitization ability. The non tumorigenic MCF10A and the tumorigenic MCF7 and MDA-MB-231 BC cell lines were used. Curcumin-loaded solid nanoparticles were prepared using ethanolic precipitation and the loading capacity was evaluated by UV spectrophotometer analysis. Cell survival after treatments was evaluated by clonogenic assay. Dose–response curves were generated testing three concentrations of free-Cur and Cur-SLN in combination with increasing doses of IR (2–9 Gy). IC50 value and Dose Modifying Factor (DMF) was measured to quantify the sensitivity to curcumin and to combined treatments. A multi-“omic” approach was used to explain the Cur-SLN radiosensitizer effect by microarray and metobolomic analysis. We have shown the efficacy of the Cur-SLN formulation as radiosensitizer on three BC cell lines. The DMFs values, calculated at the isoeffect of SF = 50%, showed that the Luminal A MCF7 resulted sensitive to the combined treatments using increasing concentration of vehicled curcumin Cur-SLN (DMF: 1,78 with 10 µM Cur-SLN.) Instead, triple negative MDA-MB-231 cells were more sensitive to free-Cur, although these cells also receive a radiosensitization effect by combination with Cur-SLN (DMF: 1.38 with 10 µM Cur-SLN). The Cur-SLN radiosensitizing function, evaluated by transcriptomic and metabolomic approach, revealed anti-oxidant and anti-tumor effects. Curcumin loaded- SLN can be suggested in future preclinical and clinical studies to test its concomitant use during radiotherapy treatments with the double implications of being a radiosensitizing molecule against cancer cells, with a protective role against IR side effects.
Collapse
Affiliation(s)
- Luigi Minafra
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy
| | - Nunziatina Porcino
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy
| | - Valentina Bravatà
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy.
| | - Daniela Gaglio
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy.,SYSBIO Centre of Systems Biology, University of Milano-Bicocca, Milano, Italy
| | - Marcella Bonanomi
- SYSBIO Centre of Systems Biology, University of Milano-Bicocca, Milano, Italy
| | - Erika Amore
- Istituto per lo Studio dei Materiali Nanostrutturati-Consiglio Nazionale delle Ricerche (ISMN-CNR), Palermo, Italy
| | - Francesco Paolo Cammarata
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy
| | - Giorgio Russo
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy
| | - Carmelo Militello
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy
| | - Gaetano Savoca
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy
| | - Margherita Baglio
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy
| | - Boris Abbate
- Medical Physics Department, ARNAS-Civico Hospital, Palermo, Italy
| | | | | | - Maria Carla Gilardi
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy.,Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
| | - Maria Luisa Bondì
- Istituto per lo Studio dei Materiali Nanostrutturati-Consiglio Nazionale delle Ricerche (ISMN-CNR), Palermo, Italy
| | - Giusi Irma Forte
- Istituto di Bioimmagini e Fisiologia Molecolare-Consiglio Nazionale delle Ricerche (IBFM-CNR), Cefalù, (PA), Italy
| |
Collapse
|
5
|
Tabeshpour J, Banaeeyeh S, Eisvand F, Sathyapalan T, Hashemzaei M, Sahebkar A. Effects of curcumin on ion channels and pumps: A review. IUBMB Life 2019; 71:812-820. [PMID: 31020791 DOI: 10.1002/iub.2054] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Revised: 04/06/2019] [Accepted: 04/10/2019] [Indexed: 12/14/2022]
Abstract
Curcumin, an orange-yellow lipophilic polyphenolic molecule, is the active component of Curcuma longa, which is extensively used as a spice in most of the Asian countries. This natural compound is able to interact with a large number of molecular structures like proteins, enzymes, lipids, DNA, RNA, transporter molecules, and ion channels. It has been reported to possess several biological effects such as antioxidant, anti-inflammatory, wound healing, antimicrobial, anticancer, antiangiogenic, antimutagenic, and antiplatelet aggregation properties. These beneficial effects of curcumin are because of its extraordinary chemical interactions such as extensive hydrogen and covalent bonding, metal chelation, and so on. Therefore, the aim of this review was to outline the evidence in which curcumin could affect different types of ion channels and ion channel-related diseases, and also to elucidate basic molecular mechanisms behind it. © 2019 IUBMB Life, 2019.
Collapse
Affiliation(s)
- Jamshid Tabeshpour
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Sara Banaeeyeh
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Farhad Eisvand
- Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Thozhukat Sathyapalan
- Department of Academic Diabetes, Endocrinology and Metabolism, Hull York Medical School, University of Hull, Hull, UK
| | - Mahmoud Hashemzaei
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran
| | - Amirhossein Sahebkar
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.,Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.,School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|
6
|
Long L, Li Y, Yu S, Li X, Hu Y, Long T, Wang L, Li W, Ye X, Ke Z, Xiao H. Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling. J Diabetes Res 2019; 2019:4875421. [PMID: 31976335 PMCID: PMC6949683 DOI: 10.1155/2019/4875421] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Revised: 10/24/2019] [Accepted: 10/30/2019] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Diabetic retinopathy (DR) is a serious microvascular complication of diabetes. This study demonstrates the antiangiogenic effects of scutellarin (SCU) on high glucose- and hypoxia-stimulated human retinal endothelial cells (HRECs) and on a diabetic rat model by oral administration. The antiangiogenic mechanisms of SCU in vitro and in vivo were investigated. METHOD HRECs were cultured in high glucose- (30 mM D-glucose) and hypoxia (cobalt chloride-treated)-stimulated diabetic condition to evaluate the antiangiogenic effects of SCU by CCK-8 test, cell migration experiment (wound healing and transwell), and tube formation experiment. A streptozotocin-induced type II diabetic rat model was established to measure the effects of oral administration of SCU on protecting retinal microvascular dysfunction by Doppler waveforms and HE staining. We further used western blot, luciferase reporter assay, and immunofluorescence staining to study the antiangiogenic mechanism of SCU. The protein levels of phospho-ERK, phospho-FAK, phospho-Src, VEGF, and PEDF were examined in HRECs and retina of diabetic rats. RESULT Our results indicated that SCU attenuated diabetes-induced HREC proliferation, migration, and tube formation and decreased neovascularization and resistive index in the retina of diabetic rats by oral administration. SCU suppressed the crosstalk of phospho-ERK, phospho-FAK, phospho-Src, and VEGF in vivo and in vitro. CONCLUSIONS These results suggested that SCU can be an oral drug to alleviate microvascular dysfunction of DR and exerts its antiangiogenic effects by inhibiting the expression of the crosstalk of VEGF, p-ERK, p-FAK, and p-Src.
Collapse
Affiliation(s)
- Lingli Long
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
- Translation Medicine Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Yubin Li
- The Reproductive Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Shuang Yu
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Xiang Li
- Department of Spine Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Yue Hu
- Translation Medicine Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Tengfei Long
- Department of Gynaecology and Obstetrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
| | - Liqin Wang
- Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Wenwen Li
- Laboratory Animal Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Xiaoxin Ye
- University of New South Wales, Sydney, High St. Kensington, NSW, Australia
| | - Zunfu Ke
- Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Haipeng Xiao
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| |
Collapse
|
7
|
Siemianowicz K, Likus W, Dorecka M, Wilk R, Dziubdziela W, Markowski J. Chemoprevention of Head and Neck Cancers: Does It Have Only One Face? BIOMED RESEARCH INTERNATIONAL 2018; 2018:9051854. [PMID: 30356371 PMCID: PMC6176306 DOI: 10.1155/2018/9051854] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Accepted: 09/03/2018] [Indexed: 12/25/2022]
Abstract
Head and neck squamous cell cancer (HNSCC) represents a significant burden worldwide. Chemoprevention of HNSCC is a means of cancer control with a use of drugs or natural agents in order to hinder or delay the cancer development. The purpose of this article is to review mechanism of action of different chemopreventive agents' groups and results of most important researches concerning them. The safety issues of HNSCC chemoprevention are also discussed. In case of HNSCC there is currently no agent, which would give positive result in the third phase of clinical trials. Promising results of preclinical trials are not always confirmed by further tests. Main problems are low effectiveness, high toxicity, and lack of highly specificity biomarkers for monitoring the research. New trials concerning many agents, as well as novel technologies for provision of pharmaceutical forms of them, including drug nanocarriers, are currently underway, which gives hope for finding the perfect chemopreventive agent formula.
Collapse
Affiliation(s)
- Krzysztof Siemianowicz
- Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Medyków 18 Str., 40-752 Katowice, Poland
| | - Wirginia Likus
- Department of Anatomy, School of Health Sciences in Katowice, Medical University of Silesia, Medyków 18 Str., 40-752 Katowice, Poland
| | - Mariola Dorecka
- Department of Ophthalmology, School of Medicine in Katowice, Medical University of Silesia, Ceglana 35 Str., 40-952 Katowice, Poland
| | - Renata Wilk
- Department of Anatomy, School of Health Sciences in Katowice, Medical University of Silesia, Medyków 18 Str., 40-752 Katowice, Poland
| | - Włodzimierz Dziubdziela
- Outpatient Clinic for Treatment of Chronic Pain, Wyszyńskiego 12 Str., 41-200 Sosnowiec, Poland
| | - Jarosław Markowski
- Department of Laryngology, School of Medicine in Katowice, Medical University of Silesia, Francuska 20/24 Str., 40-027 Katowice, Poland
| |
Collapse
|
8
|
Liu HT, Ho YS. Anticancer effect of curcumin on breast cancer and stem cells. FOOD SCIENCE AND HUMAN WELLNESS 2018. [DOI: 10.1016/j.fshw.2018.06.001] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
9
|
El Nebrisi EG, Bagdas D, Toma W, Al Samri H, Brodzik A, Alkhlaif Y, Yang KHS, Howarth FC, Damaj IM, Oz M. Curcumin Acts as a Positive Allosteric Modulator of α7-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain. J Pharmacol Exp Ther 2018; 365:190-200. [PMID: 29339457 DOI: 10.1124/jpet.117.245068] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2017] [Accepted: 12/27/2017] [Indexed: 12/11/2022] Open
Abstract
Effects of curcumin, a major ingredient of turmeric, were tested on the function of the α7-subunit of the human nicotinic acetylcholine (α7-nACh) receptor expressed in Xenopus oocytes and on nociception in mouse models of tonic and visceral pain. Curcumin caused a significant potentiation of currents induced by acetylcholine (ACh; 100 μM) with an EC50 value of 0.2 µM. The effect of curcumin was not dependent on the activation of G-proteins and protein kinases and did not involve Ca2+-dependent Cl- channels expressed endogenously in oocytes. Importantly, the extent of curcumin potentiation was enhanced significantly by decreasing ACh concentrations. Curcumin did not alter specific binding of [125I]α-bungarotoxin. In addition, curcumin attenuated nociceptive behavior in both tonic and visceral pain models without affecting motor and locomotor activity and without producing tolerance. Pharmacological and genetic approaches revealed that the antinociceptive effect of curcumin was mediated by α7-nACh receptors. Curcumin potentiated the antinociceptive effects of the α7-nACh receptor agonist N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU282987). Collectively, our results indicate that curcumin is a positive allosteric modulator of α7-nACh receptor and reverses nociception in mouse models of tonic and visceral pain.
Collapse
Affiliation(s)
- Eslam Gaber El Nebrisi
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Deniz Bagdas
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Wisam Toma
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Halima Al Samri
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Anna Brodzik
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Yasmin Alkhlaif
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Keun-Hang Susan Yang
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Frank Christopher Howarth
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Imad M Damaj
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| | - Murat Oz
- Departments of Pharmacology (E.G.E.N., H.A.S., M.O.) and Physiology (F.C.H.), College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates; Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia (D.B., W.T., A.B., Y.A., I.M.D.); Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey (D.B.); Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, One University Drive, Orange, California (K.-H.S.Y.); and Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha, Qatar (M.O.)
| |
Collapse
|
10
|
Banik U, Parasuraman S, Adhikary AK, Othman NH. Curcumin: the spicy modulator of breast carcinogenesis. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH : CR 2017; 36:98. [PMID: 28724427 PMCID: PMC5517797 DOI: 10.1186/s13046-017-0566-5] [Citation(s) in RCA: 79] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/15/2017] [Accepted: 07/10/2017] [Indexed: 12/22/2022]
Abstract
Worldwide breast cancer is the most common cancer in women. For many years clinicians and the researchers are examining and exploring various therapeutic modalities for breast cancer. Yet the disease has remained unconquered and the quest for cure is still going on. Present-day strategy of breast cancer therapy and prevention is either combination of a number of drugs or a drug that modulates multiple targets. In this regard natural products are now becoming significant options. Curcumin exemplifies a promising natural anticancer agent for this purpose. This review primarily underscores the modulatory effect of curcumin on the cancer hallmarks. The focus is its anticancer effect in the complex pathways of breast carcinogenesis. Curcumin modulates breast carcinogenesis through its effect on cell cycle and proliferation, apoptosis, senescence, cancer spread and angiogenesis. Largely the NFkB, PI3K/Akt/mTOR, MAPK and JAK/STAT are the key signaling pathways involved. The review also highlights the curcumin mediated modulation of tumor microenvironment, cancer immunity, breast cancer stem cells and cancer related miRNAs. Using curcumin as a therapeutic and preventive agent in breast cancer is perplexed by its diverse biological activity, much of which remains inexplicable. The information reviewed here should point toward potential scope of future curcumin research in breast cancer.
Collapse
Affiliation(s)
- Urmila Banik
- Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia.,Unit of Pathology, AIMST University, Faculty of Medicine, Semeling, 08100, Bedong, Kedah, Malaysia
| | - Subramani Parasuraman
- Unit of Pharmacology, AIMST University, Faculty of Pharmacy, Semeling, 08100, Bedong, Kedah, Malaysia
| | - Arun Kumar Adhikary
- Unit of Microbiology, AIMST University, Faculty of Medicine, Semeling, 08100, Bedong, Kedah, Malaysia
| | - Nor Hayati Othman
- Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia.
| |
Collapse
|
11
|
Martínez-Cifuentes M, Weiss-López B, Araya-Maturana R. A Computational Study of Structure and Reactivity of N-Substitued-4-Piperidones Curcumin Analogues and Their Radical Anions. Molecules 2016; 21:molecules21121658. [PMID: 27918440 PMCID: PMC6273823 DOI: 10.3390/molecules21121658] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2016] [Revised: 11/25/2016] [Accepted: 11/28/2016] [Indexed: 02/02/2023] Open
Abstract
In this work, a computational study of a series of N-substitued-4-piperidones curcumin analogues is presented. The molecular structure of the neutral molecules and their radical anions, as well as their reactivity, are investigated. N-substituents include methyl and benzyl groups, while substituents on the aromatic rings cover electron-donor and electron-acceptor groups. Substitutions at the nitrogen atom do not significantly affect the geometry and frontier molecular orbitals (FMO) energies of these molecules. On the other hand, substituents on the aromatic rings modify the distribution of FMO. In addition, they influence the capability of these molecules to attach an additional electron, which was studied through adiabatic (AEA) and vertical electron affinities (VEA), as well as vertical detachment energy (VDE). To study electrophilic properties of these structures, local reactivity indices, such as Fukui (f+) and Parr (P+) functions, were calculated, and show the influence of the aromatic rings substituents on the reactivity of α,β-unsaturated ketones towards nucleophilic attack. This study has potential implications for the design of curcumin analogues based on a 4-piperidone core with desired reactivity.
Collapse
Affiliation(s)
- Maximiliano Martínez-Cifuentes
- Programa Institucional de Fomento a la Investigación, Desarrollo e Innovación, Universidad Tecnológica Metropolitana, Ignacio Valdivieso 2409, Casilla 9845, Santiago 8940577, Chile.
| | - Boris Weiss-López
- Departamento de Química, Facultad de Ciencias, Universidad de Chile, Las Palmeras 3425, Casilla 653, Santiago 7800003, Chile.
| | - Ramiro Araya-Maturana
- Instituto de Química de Recursos Naturales, Universidad de Talca, Av. Lircay s/n, Casilla 747, Talca 3460000, Chile.
| |
Collapse
|
12
|
Pavan AR, Silva GDBD, Jornada DH, Chiba DE, Fernandes GFDS, Man Chin C, Dos Santos JL. Unraveling the Anticancer Effect of Curcumin and Resveratrol. Nutrients 2016; 8:nu8110628. [PMID: 27834913 PMCID: PMC5133053 DOI: 10.3390/nu8110628] [Citation(s) in RCA: 78] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2016] [Revised: 09/24/2016] [Accepted: 09/27/2016] [Indexed: 12/16/2022] Open
Abstract
Resveratrol and curcumin are natural products with important therapeutic properties useful to treat several human diseases, including cancer. In the last years, the number of studies describing the effect of both polyphenols against cancer has increased; however, the mechanism of action in all of those cases is not completely comprehended. The unspecific effect and the ability to interfere in assays by both polyphenols make this challenge even more difficult. Herein, we analyzed the anticancer activity of resveratrol and curcumin reported in the literature in the last 11 years, in order to unravel the molecular mechanism of action of both compounds. Molecular targets and cellular pathways will be described. Furthermore, we also discussed the ability of these natural products act as chemopreventive and its use in association with other anticancer drugs.
Collapse
Affiliation(s)
- Aline Renata Pavan
- School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Araraquara 14800903, Brazil.
| | | | | | - Diego Eidy Chiba
- School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Araraquara 14800903, Brazil.
| | | | - Chung Man Chin
- School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Araraquara 14800903, Brazil.
| | - Jean Leandro Dos Santos
- School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Araraquara 14800903, Brazil.
| |
Collapse
|
13
|
Moustapha A, Pérétout PA, Rainey NE, Sureau F, Geze M, Petit JM, Dewailly E, Slomianny C, Petit PX. Curcumin induces crosstalk between autophagy and apoptosis mediated by calcium release from the endoplasmic reticulum, lysosomal destabilization and mitochondrial events. Cell Death Discov 2015; 1:15017. [PMID: 27551451 PMCID: PMC4979459 DOI: 10.1038/cddiscovery.2015.17] [Citation(s) in RCA: 89] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2015] [Accepted: 06/23/2015] [Indexed: 12/22/2022] Open
Abstract
Curcumin, a major active component of turmeric (Curcuma longa, L.), has anticancer effects. In vitro studies suggest that curcumin inhibits cancer cell growth by activating apoptosis, but the mechanism underlying these effects is still unclear. Here, we investigated the mechanisms leading to apoptosis in curcumin-treated cells. Curcumin induced endoplasmic reticulum stress causing calcium release, with a destabilization of the mitochondrial compartment resulting in apoptosis. These events were also associated with lysosomal membrane permeabilization and of caspase-8 activation, mediated by cathepsins and calpains, leading to Bid cleavage. Truncated tBid disrupts mitochondrial homeostasis and enhance apoptosis. We followed the induction of autophagy, marked by the formation of autophagosomes, by staining with acridine orange in cells exposed curcumin. At this concentration, only the early events of apoptosis (initial mitochondrial destabilization with any other manifestations) were detectable. Western blotting demonstrated the conversion of LC3-I to LC3-II (light chain 3), a marker of active autophagosome formation. We also found that the production of reactive oxygen species and formation of autophagosomes following curcumin treatment was almost completely blocked by N-acetylcystein, the mitochondrial specific antioxidants MitoQ10 and SKQ1, the calcium chelators, EGTA-AM or BAPTA-AM, and the mitochondrial calcium uniporter inhibitor, ruthenium red. Curcumin-induced autophagy failed to rescue all cells and most cells underwent type II cell death following the initial autophagic processes. All together, these data imply a fail-secure mechanism regulated by autophagy in the action of curcumin, suggesting a therapeutic potential for curcumin. Offering a novel and effective strategy for the treatment of malignant cells.
Collapse
Affiliation(s)
- A Moustapha
- INSERM U1124 'Toxicologie, Pharmacologie et Signalisation Cellulaire', Université Paris-Descartes, Centre Universitaire des Saints-Pères , Paris, France
| | - P A Pérétout
- INSERM U1124 'Toxicologie, Pharmacologie et Signalisation Cellulaire', Université Paris-Descartes, Centre Universitaire des Saints-Pères , Paris, France
| | - N E Rainey
- INSERM U1124 'Toxicologie, Pharmacologie et Signalisation Cellulaire', Université Paris-Descartes, Centre Universitaire des Saints-Pères , Paris, France
| | - F Sureau
- Université Pierre et Marie Curie-Paris 6, Laboratoire Jean Perrin , Paris, France
| | - M Geze
- Muséum National d'Histoire Naturelles, CeMIM/USM 0504, 'Biologie Fonctionnelles des Protozoaires' 57 , Paris, France
| | - J-M Petit
- Muséum National d'Histoire Naturelles, UMR 7245 CNRS/MNHN 'Molécules de Communication et Adaptation des Micro-organismes' 57 , Paris, France
| | - E Dewailly
- Laboratoire de Physiologie cellulaire, INSERM U800, Université des Sciences et Techniques de Lille 1 , Villeneuve d'Ascq, France
| | - C Slomianny
- Laboratoire de Physiologie cellulaire, INSERM U800, Université des Sciences et Techniques de Lille 1 , Villeneuve d'Ascq, France
| | - P X Petit
- INSERM U1124 'Toxicologie, Pharmacologie et Signalisation Cellulaire', Université Paris-Descartes, Centre Universitaire des Saints-Pères , Paris, France
| |
Collapse
|
14
|
Byun SY, Kim DB, Kim E. Curcumin ameliorates the tumor-enhancing effects of a high-protein diet in an azoxymethane-induced mouse model of colon carcinogenesis. Nutr Res 2015; 35:726-35. [PMID: 26094212 DOI: 10.1016/j.nutres.2015.05.016] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2014] [Revised: 05/15/2015] [Accepted: 05/27/2015] [Indexed: 02/06/2023]
Abstract
An increasing number of reports suggest that a high-protein diet (HPD) is associated with an increased risk for colorectal cancer (CRC). One of the proposed mechanisms is that an HPD increases the delivery of protein to the colon and generates various toxic metabolites that contribute to colon carcinogenesis. Curcumin was shown to exert significant preventive properties against CRC. We therefore hypothesized that curcumin can reverse the tumor-enhancing effects of an HPD. This study examined the effects of curcumin on the development of azoxymethane (AOM)-induced colorectal tumors in HPD-fed mice. A total of 30 female Balb/c mice were randomly divided into 3 groups: those fed a normal diet (20% casein), those fed an HPD (HPD; 50% casein), and those fed an HPD supplemented with curcumin (HPDC; 0.02% curcumin). The mice were subjected to an AOM-dextran sodium sulfate colon carcinogenesis protocol. Mice in the HPDC group exhibited a significant (40%) reduction in colorectal tumor multiplicity when compared with those in the HPD group. The expression of colonic inflammatory proteins (cyclooxygenase-2 and inducible nitric oxide synthase), the levels of plasma inflammatory markers (nitric oxide and tumor necrosis factor-α), fecal ammonia, short- and branched-chain fatty acid levels, and the rate of colonocyte proliferation were significantly lower in the HPDC than the HPD group. In conclusion, curcumin inhibited the development of colorectal tumors in an AOM-induced mouse model of colon carcinogenesis by attenuating colonic inflammation, proliferation, and toxic metabolite production. Curcumin might be useful in the chemoprevention of CRC in individuals consuming an HPD.
Collapse
Affiliation(s)
- So-Young Byun
- Department of Food Science and Nutrition, Catholic University of Daegu, Gyeongsan, Korea
| | - Dan-Bi Kim
- Department of Food Science and Nutrition, Catholic University of Daegu, Gyeongsan, Korea
| | - Eunjung Kim
- Department of Food Science and Nutrition, Catholic University of Daegu, Gyeongsan, Korea.
| |
Collapse
|
15
|
Picone P, Nuzzo D, Caruana L, Messina E, Scafidi V, Di Carlo M. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of AKT and Foxo3a nuclear translocation. Free Radic Res 2014; 48:1397-408. [DOI: 10.3109/10715762.2014.960410] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
16
|
Kim H, Park J, Tak KH, Bu SY, Kim E. Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice. In Vitro Cell Dev Biol Anim 2014; 50:883-92. [DOI: 10.1007/s11626-014-9791-9] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2014] [Accepted: 06/11/2014] [Indexed: 12/16/2022]
|
17
|
Stephens L, Whitehouse J, Polley M. Western herbal medicine, epigenetics, and endometriosis. J Altern Complement Med 2013; 19:853-9. [PMID: 23738681 DOI: 10.1089/acm.2012.0623] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
Endometriosis is an enigmatic disease characterized by the presence and growth of endometrial-like tissue outside the uterine cavity. The etiology of endometriosis is poorly understood, yet recent evidence suggests that epigenetic aberrations and heritable changes in the genome may be the key to understanding how to approach this disease. Difficulty in long-term management of endometriosis symptoms and unpredictability of treatment outcome necessitate research into other treatment modalities, such as Western herbal medicine. This article reviews commonly used herbs in the treatment of endometriosis, the effects of phytochemical constituents on endometrial cells, and the impact on the epigenome.
Collapse
Affiliation(s)
- Lucy Stephens
- School of Life Sciences, University of Westminster , London, United Kingdom
| | | | | |
Collapse
|